vs
GRAN TIERRA ENERGY INC.（GTE）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
REPLIGEN CORP的季度营收约是GRAN TIERRA ENERGY INC.的1.6倍（$197.9M vs $124.4M），REPLIGEN CORP净利率更高（6.7% vs -113.4%，领先120.1%），REPLIGEN CORP同比增速更快（13.6% vs -15.5%），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs -11.1%）
Gran Tierra Energy是一家2005年5月成立的能源企业，总部位于加拿大阿尔伯塔省卡尔加里，业务核心聚焦南美地区的油气勘探、开发与生产，曾于2008年7月宣布计划与Solana Resources完成合并。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
GTE vs RGEN — 直观对比
营收规模更大
RGEN
是对方的1.6倍
$124.4M
营收增速更快
RGEN
高出29.2%
-15.5%
净利率更高
RGEN
高出120.1%
-113.4%
两年增速更快
RGEN
近两年复合增速
-11.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $124.4M | $197.9M |
| 净利润 | $-141.1M | $13.3M |
| 毛利率 | — | 52.5% |
| 营业利润率 | -142.9% | 9.0% |
| 净利率 | -113.4% | 6.7% |
| 营收同比 | -15.5% | 13.6% |
| 净利润同比 | -312.6% | 143.9% |
| 每股收益（稀释后） | $-3.98 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GTERGEN
| Q4 25 | $124.4M | $197.9M | ||
| Q3 25 | $149.3M | $188.8M | ||
| Q2 25 | $152.5M | $182.4M | ||
| Q1 25 | $170.5M | $169.2M | ||
| Q4 24 | $147.3M | $174.1M | ||
| Q3 24 | $151.4M | $154.9M | ||
| Q2 24 | $165.6M | $154.1M | ||
| Q1 24 | $157.6M | $151.3M |
净利润GTERGEN
| Q4 25 | $-141.1M | $13.3M | ||
| Q3 25 | $-19.9M | $14.9M | ||
| Q2 25 | $-12.7M | $14.9M | ||
| Q1 25 | $-19.3M | $5.8M | ||
| Q4 24 | $-34.2M | $-30.3M | ||
| Q3 24 | $1.1M | $-654.0K | ||
| Q2 24 | $36.4M | $3.3M | ||
| Q1 24 | $-78.0K | $2.1M |
毛利率GTERGEN
| Q4 25 | — | 52.5% | ||
| Q3 25 | — | 53.2% | ||
| Q2 25 | — | 50.0% | ||
| Q1 25 | — | 53.6% | ||
| Q4 24 | — | 26.1% | ||
| Q3 24 | — | 50.0% | ||
| Q2 24 | — | 49.8% | ||
| Q1 24 | — | 49.5% |
营业利润率GTERGEN
| Q4 25 | -142.9% | 9.0% | ||
| Q3 25 | -20.9% | 8.9% | ||
| Q2 25 | -5.3% | 7.6% | ||
| Q1 25 | -9.2% | 3.9% | ||
| Q4 24 | -14.9% | -17.7% | ||
| Q3 24 | 14.5% | -5.1% | ||
| Q2 24 | 16.5% | 1.0% | ||
| Q1 24 | 11.0% | 1.3% |
净利率GTERGEN
| Q4 25 | -113.4% | 6.7% | ||
| Q3 25 | -13.4% | 7.9% | ||
| Q2 25 | -8.4% | 8.2% | ||
| Q1 25 | -11.3% | 3.4% | ||
| Q4 24 | -23.2% | -17.4% | ||
| Q3 24 | 0.7% | -0.4% | ||
| Q2 24 | 22.0% | 2.2% | ||
| Q1 24 | -0.0% | 1.4% |
每股收益（稀释后）GTERGEN
| Q4 25 | $-3.98 | $0.24 | ||
| Q3 25 | $-0.57 | $0.26 | ||
| Q2 25 | $-0.36 | $0.26 | ||
| Q1 25 | $-0.54 | $0.10 | ||
| Q4 24 | $-1.10 | $-0.55 | ||
| Q3 24 | $0.04 | $-0.01 | ||
| Q2 24 | $1.16 | $0.06 | ||
| Q1 24 | $0.00 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $82.9M | $767.6M |
| 总债务越低越好 | $686.5M | $542.2M |
| 股东权益账面价值 | $228.7M | $2.1B |
| 总资产 | $1.6B | $2.9B |
| 负债/权益比越低杠杆越低 | 3.00× | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资GTERGEN
| Q4 25 | $82.9M | $767.6M | ||
| Q3 25 | $49.1M | $748.7M | ||
| Q2 25 | $61.0M | $708.9M | ||
| Q1 25 | $76.6M | $697.2M | ||
| Q4 24 | $103.4M | $757.4M | ||
| Q3 24 | $277.6M | $784.0M | ||
| Q2 24 | $115.3M | $809.1M | ||
| Q1 24 | $126.6M | $780.6M |
总债务GTERGEN
| Q4 25 | $686.5M | $542.2M | ||
| Q3 25 | $761.8M | $537.9M | ||
| Q2 25 | $772.6M | — | ||
| Q1 25 | $726.3M | — | ||
| Q4 24 | $722.1M | $525.6M | ||
| Q3 24 | $718.4M | — | ||
| Q2 24 | $582.1M | — | ||
| Q1 24 | $583.1M | — |
股东权益GTERGEN
| Q4 25 | $228.7M | $2.1B | ||
| Q3 25 | $366.0M | $2.1B | ||
| Q2 25 | $389.8M | $2.1B | ||
| Q1 25 | $393.8M | $2.0B | ||
| Q4 24 | $413.6M | $2.0B | ||
| Q3 24 | $420.9M | $2.0B | ||
| Q2 24 | $420.9M | $2.0B | ||
| Q1 24 | $392.0M | $2.0B |
总资产GTERGEN
| Q4 25 | $1.6B | $2.9B | ||
| Q3 25 | $1.7B | $2.9B | ||
| Q2 25 | $1.7B | $2.9B | ||
| Q1 25 | $1.7B | $2.9B | ||
| Q4 24 | $1.7B | $2.8B | ||
| Q3 24 | $1.5B | $2.8B | ||
| Q2 24 | $1.4B | $2.9B | ||
| Q1 24 | $1.4B | $2.8B |
负债/权益比GTERGEN
| Q4 25 | 3.00× | 0.26× | ||
| Q3 25 | 2.08× | 0.26× | ||
| Q2 25 | 1.98× | — | ||
| Q1 25 | 1.84× | — | ||
| Q4 24 | 1.75× | 0.27× | ||
| Q3 24 | 1.71× | — | ||
| Q2 24 | 1.38× | — | ||
| Q1 24 | 1.49× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $157.2M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | — | $17.6M |
| 自由现金流率自由现金流/营收 | — | 8.9% |
| 资本支出强度资本支出/营收 | — | 4.1% |
| 现金转化率经营现金流/净利润 | — | 1.93× |
| 过去12个月自由现金流最近4个季度 | — | $93.9M |
8季度趋势，按日历期对齐
经营现金流GTERGEN
| Q4 25 | $157.2M | $25.7M | ||
| Q3 25 | $48.1M | $48.1M | ||
| Q2 25 | $34.7M | $28.6M | ||
| Q1 25 | $73.2M | $15.0M | ||
| Q4 24 | $26.6M | $39.2M | ||
| Q3 24 | $78.7M | $49.3M | ||
| Q2 24 | $73.2M | $42.2M | ||
| Q1 24 | $60.8M | $44.7M |
自由现金流GTERGEN
| Q4 25 | — | $17.6M | ||
| Q3 25 | — | $43.4M | ||
| Q2 25 | — | $21.5M | ||
| Q1 25 | — | $11.4M | ||
| Q4 24 | — | $33.6M | ||
| Q3 24 | — | $42.3M | ||
| Q2 24 | — | $37.4M | ||
| Q1 24 | — | $36.4M |
自由现金流率GTERGEN
| Q4 25 | — | 8.9% | ||
| Q3 25 | — | 23.0% | ||
| Q2 25 | — | 11.8% | ||
| Q1 25 | — | 6.8% | ||
| Q4 24 | — | 19.3% | ||
| Q3 24 | — | 27.3% | ||
| Q2 24 | — | 24.3% | ||
| Q1 24 | — | 24.0% |
资本支出强度GTERGEN
| Q4 25 | — | 4.1% | ||
| Q3 25 | — | 2.5% | ||
| Q2 25 | — | 3.9% | ||
| Q1 25 | — | 2.1% | ||
| Q4 24 | — | 3.2% | ||
| Q3 24 | — | 4.5% | ||
| Q2 24 | — | 3.1% | ||
| Q1 24 | — | 5.5% |
现金转化率GTERGEN
| Q4 25 | — | 1.93× | ||
| Q3 25 | — | 3.23× | ||
| Q2 25 | — | 1.92× | ||
| Q1 25 | — | 2.57× | ||
| Q4 24 | — | — | ||
| Q3 24 | 69.42× | — | ||
| Q2 24 | 2.01× | 12.70× | ||
| Q1 24 | — | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GTE
| Colombia Segment | $89.1M | 72% |
| Other | $22.9M | 18% |
| Ecuador Segment | $12.5M | 10% |
RGEN
暂无分部数据
